Filing metadata

Accession number
0001104659-17-035349
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
May 25, 2017
Reporting period
May 23, 2017
Description
Insider transaction

Explore SEC Filings Hub